Waters and Rosetta Biosoftware Collaborate to Advance the Analysis of Complex Biological Mixtures
News May 31, 2007
Specifically, the companies will work together to ensure that Rosetta Biosoftware's solution for protein expression data management and analysis, the Rosetta Elucidator® system, will process and analyze mass spectrometry data generated from the Waters® Q-Tof Premier™ and Synapt™ High Definition Mass Spectrometry™ (HDMS) Systems.
The collaboration will focus on developing software interfaces between the Elucidator system and Waters instrument systems that will give scientists the capability to perform comprehensive qualitative and quantitative profiling of complex biological mixtures.
"We are pleased to enable compatibility between the Elucidator system, and our innovative UPLC/MSE data acquisition methods and instruments," said Tim Riley, Vice President and Managing Director – Pharmaceutical Business Operations, Waters Division.
"This collaboration will enable more of our customers to take advantage of our advanced mass spec technologies to comprehensively analyze the results of their most demanding experiments," Riley added.
"Collaboration with Waters will allow us to rapidly adapt to advances in Waters instrument technology, ensuring that our customers have continued access to a robust end-to-end solution," said Yelena Shevelenko, Vice President and General Manager of Rosetta Biosoftware. "The streamlined integration will improve research productivity and provide solutions for a broader scientific audience."
The Waters Corporation and Rosetta Biosoftware will be exhibiting their latest technologies at the 55th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, June 3 - 7, 2007 in Indianapolis, Indiana.
Genetic Variations in the Lungs Identify COPD RiskNews
Developmental genetic variations in the anatomy of the lung could indicate people at risk of COPD later in life, a study suggests.READ MORE
Proteasome Blocker Brings Glaucoma Gene Therapy CloserNews
An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.READ MORE
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE